将泌尿生殖系统恶性肿瘤诊疗集中至高容量医疗提供者的影响:一项系统综述
本系统综述检索1970至2018年文献,纳入22项回顾性研究,未发现随机对照试验。结果显示,由高容量医疗提供者治疗膀胱癌、前列腺癌、阴茎癌、睾丸癌和肾癌与更好的生存结局和更低发病率相关,其中根治性膀胱切除术的集中化证据最充分;但因数据缺乏或发病率较低,阴茎癌、肾癌和睾丸癌的集中化获益证据仍有限。
要点
- 未发现关于泌尿生殖系统恶性肿瘤诊疗集中化的随机对照试验,纳入22项回顾性研究。
- 根治性膀胱切除术的集中化研究最多,高容量中心治疗与更好的发病率和生存结局相关。
- 阴茎癌、肾癌和睾丸癌的集中化获益证据因数据缺乏或发病率较低而仍有限。
核心结论
- 由高容量医疗提供者治疗泌尿生殖系统恶性肿瘤与更高的癌症手术利用率、更低的发病率和更好的生存结局相关。
- 在生存结局背景下解读时,诊疗集中化最适合根治性膀胱切除术等复杂手术。
- 需要进一步研究以解决所有泌尿系统恶性肿瘤诊疗集中化的影响,并考虑相关成本和患者报告指标,包括生活质量和患者体验。
研究设计与样本
- 系统综述,使用Ovid和MEDLINE检索1970年至2018年间报告泌尿生殖系统恶性肿瘤诊疗集中化的研究。
- 筛选前瞻性和回顾性研究;未发现关于泌尿生殖系统恶性肿瘤诊疗集中化的随机对照试验。
- 共纳入22项回顾性研究。
主要发现
- 根治性膀胱切除术的集中化是研究最多的。
- 据报道,膀胱癌、前列腺癌、阴茎癌、睾丸癌和肾癌的诊疗在高容量中心治疗的患者中与更好的发病率和生存结局相关。
- 然而,由于数据缺乏和/或这些泌尿生殖系统恶性肿瘤发病率较低,阴茎癌、肾癌和睾丸癌诊疗集中化获得更好结局的证据仍然有限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未发现关于泌尿生殖系统恶性肿瘤诊疗集中化的随机对照试验。
- 阴茎癌、肾癌和睾丸癌诊疗集中化获得更好结局的证据因数据缺乏和/或这些泌尿生殖系统恶性肿瘤发病率较低而仍然有限。
- 需要进一步研究以解决所有泌尿系统恶性肿瘤诊疗集中化的影响,并考虑相关成本和患者报告指标,包括生活质量和患者体验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The centralization of cancer care is associated with better clinical outcomes and may be a method for optimizing value-based health care systems. OBJECTIVE: To systematically review the literature regarding the impact of centralization of care on clinical outcomes for genitourinary malignancies. EVIDENCE ACQUISITION: A systematic review was conducted using Ovid and MEDLINE to identify studies between 1970 and 2018 reporting on the centralization of care for genitourinary malignancies. Prospective and retrospective studies were screened. EVIDENCE SYNTHESIS: There were no published randomized control trials (RCTs) on the centralization of care for genitourinary malignancies. Twenty-two retrospective studies met inclusion criteria. Centralization of radical cystectomy was the most studied. Care for bladder cancer, prostate cancer, penile cancer, testicular cancer, and renal cancer was reportedly associated with better morbidity and survival outcomes for patients treated at high-volume centers. However, evidence of better outcomes for centralization of care remains limited for penile, renal, and testicular cancers owing to the paucity of data and/or the lower incidence of these genitourinary malignancies. CONCLUSIONS: Care for genitourinary malignancies by high-volume providers was associated with greater utilization of cancer surgery, lower morbidity, and better survival outcomes. Centralization of care was most appropriate for complex procedures such as radical cystectomy when interpreted in the context of survival outcomes. Further research is needed to address the impact of centralizing care for all urologic malignancies with consideration of the associated costs and patient-reported measures, including quality of life and patient experience. PATIENT SUMMARY: We explored the evidence for moving major operations into larger centers. We focused on surgery for cancers of the bladder, prostate, testicle, penis, and kidney, and found that larger-volume hospitals had better survival outcomes and fewer complications when compared to smaller hospitals. The difference may be greatest for complex major surgeries such as radical cystectomy.
引用
- Williams SB, Ray-Zack MD, Hudgins HK, et al. Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review. Eur Urol Oncol. 2018. PMID: 31200840. doi:10.1016/j.euo.2018.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。